Just before the 23andMe SPAC deal closed, the stock belonging to its merger ... giving investors the impression it is a ...

Me on Sunday filed for bankruptcy in the U.S. after struggling with weak demand for its ancestry testing kits and a 2023 data ...

Me is pursuing a sale after filing for bankruptcy, leading many customers to look into deleting their data from the company.

Competitors like AncestryDNA and MyHeritage, both vying for customers in the at-home genetics and health space ... used by 23andMe, drawn from customer at-home testing kits, poses risks of ...

But since 23andMe is not a medical provider it does not have to abide by standard privacy policies that must be followed at a doctor's office. Such services are "not regulated well," said Ayday.

Popular DNA research company 23andMe has filed for Chapter 11 bankruptcy protection. If you sent in your saliva to learn about your ancestry or health, you may want to delete that data soon before ...

Despite the bankruptcy filing, 23andMe assures that its data storage and protection protocols remain unchanged. However, privacy experts advise users to delete their data due to potential risks of ...

23andMe is going bankrupt — underscoring the great risks of investing in many of the companies that have gone public via mergers with special-purpose acquisition corporations. When companies opt ...

23andMe bankruptcy underscores the risk of investing in most SPACs. - MarketWatch photo illustration/iStockphoto 23andMe is going bankrupt — underscoring the great ...

Just before the 23andMe SPAC deal closed ... giving investors the impression it is a risk-free investment. Some companies do not find appropriate acquisition targets and have to redeem the ...